Clinical trial
Patients With Renal Impairment Undergoing CT
NCT00292487 · Bracco Diagnostics, Inc, Industry · Completed
Key facts
| NCT number | NCT00292487 |
|---|---|
| Title | Patients With Renal Impairment Undergoing CT |
| Official title | Isovue and Visipaque in Renally Impaired Patients Undergoing CT |
| Lead sponsor | Bracco Diagnostics, Inc, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Contrast Induced Nephropathy |
| Intervention type | Drug |
| Interventions | Iopamidol 370 mgI/mL |
| Enrollment | 150 |
| Start date | Nov 1, 2004 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | Feb 16, 2006 |
| Last update posted | Feb 8, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: